1. Home
  2. CUZ vs GH Comparison

CUZ vs GH Comparison

Compare CUZ & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cousins Properties Incorporated

CUZ

Cousins Properties Incorporated

HOLD

Current Price

$24.93

Market Cap

4.2B

Sector

Real Estate

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$98.28

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUZ
GH
Founded
1958
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
14.1B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CUZ
GH
Price
$24.93
$98.28
Analyst Decision
Buy
Strong Buy
Analyst Count
10
21
Target Price
$31.10
$95.29
AVG Volume (30 Days)
1.3M
2.3M
Earning Date
02-05-2026
10-29-2025
Dividend Yield
5.11%
N/A
EPS Growth
3.48
N/A
EPS
0.35
N/A
Revenue
$955,949,000.00
$902,569,000.00
Revenue This Year
$14.95
$34.72
Revenue Next Year
$2.68
$26.46
P/E Ratio
$72.21
N/A
Revenue Growth
15.46
30.38
52 Week Low
$24.07
$29.91
52 Week High
$31.59
$112.43

Technical Indicators

Market Signals
Indicator
CUZ
GH
Relative Strength Index (RSI) 43.04 48.59
Support Level $24.90 $96.28
Resistance Level $25.52 $105.01
Average True Range (ATR) 0.51 4.13
MACD 0.05 -1.83
Stochastic Oscillator 46.63 14.27

Price Performance

Historical Comparison
CUZ
GH

About CUZ Cousins Properties Incorporated

Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: